• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌:治疗进展与筛查需求。

Esophageal cancer: Treatment advances and need for screening.

机构信息

Daniel C. Eisner is the owner of Systolica LLC, consulting and medical supplies, based in Bel Air, Md. The author has disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2024 Apr 1;37(4):19-24. doi: 10.1097/01.JAA.0001007328.84376.da. Epub 2024 Mar 26.

DOI:10.1097/01.JAA.0001007328.84376.da
PMID:38484297
Abstract

Esophageal cancer is a challenging malignancy that often is diagnosed in advanced stages, resulting in a poor prognosis. This article provides a comprehensive review of the two main types of esophageal cancer, esophageal squamous cell carcinoma and esophageal adenocarcinoma, and reviews epidemiology, risk factors, pathogenesis, diagnostic modalities, staging systems, and established and emerging treatments. Recent advancements in treatment for resectable and unresectable esophageal cancer also are explored. These include immunotherapy, targeted therapy, sentinel lymph node mapping, radiogenomics, palliative measures, and screening measures.

摘要

食管癌是一种具有挑战性的恶性肿瘤,通常在晚期诊断,预后不良。本文全面回顾了两种主要类型的食管癌,即食管鳞状细胞癌和食管腺癌,并回顾了流行病学、危险因素、发病机制、诊断方式、分期系统以及已确立和新兴的治疗方法。还探讨了可切除和不可切除食管癌的治疗新进展,包括免疫治疗、靶向治疗、前哨淋巴结绘图、放射组学、姑息治疗和筛查措施。

相似文献

1
Esophageal cancer: Treatment advances and need for screening.食管癌:治疗进展与筛查需求。
JAAPA. 2024 Apr 1;37(4):19-24. doi: 10.1097/01.JAA.0001007328.84376.da. Epub 2024 Mar 26.
2
Role of intraoperative sentinel lymph node mapping in the management of carcinoma of the esophagus.术中前哨淋巴结定位在食管癌治疗中的作用。
Saudi J Gastroenterol. 2010 Jul-Sep;16(3):168-73. doi: 10.4103/1319-3767.65186.
3
Sentinel node biopsy during thoracolaparoscopic esophagectomy for advanced esophageal cancer.晚期食管癌胸腹腔镜联合食管切除术中的前哨淋巴结活检
World J Surg Oncol. 2016 Apr 19;14:117. doi: 10.1186/s12957-016-0866-9.
4
Feasibility study of sentinel lymph node biopsy in esophageal cancer with conservative lymphadenectomy.探讨在保留淋巴结清扫的食管癌中前哨淋巴结活检的可行性。
Surg Endosc. 2011 Mar;25(3):817-25. doi: 10.1007/s00464-010-1265-x. Epub 2010 Aug 20.
5
Sentinel node identification using technetium-99m neomannosyl human serum albumin in esophageal cancer.锝-99m 新型 Mannosyl 人血清白蛋白在食管癌前哨淋巴结识别中的应用。
Ann Thorac Surg. 2011 May;91(5):1517-22. doi: 10.1016/j.athoracsur.2011.01.016. Epub 2011 Mar 5.
6
Clinical Significance of Sentinel Node Positivity in Patients with Superficial Esophageal Cancer.浅表性食管癌患者前哨淋巴结阳性的临床意义
World J Surg. 2015 Dec;39(12):2941-7. doi: 10.1007/s00268-015-3217-z.
7
Sentinel lymph node biopsy in esophageal cancer: should it be standard of care?食管癌前哨淋巴结活检:是否应成为标准治疗?
J Gastrointest Surg. 2011 Oct;15(10):1762-8. doi: 10.1007/s11605-011-1634-3. Epub 2011 Aug 2.
8
Application of Pathological Staging in Esophageal Squamous Cell Carcinoma.病理分期在食管鳞状细胞癌中的应用。
Methods Mol Biol. 2020;2129:19-31. doi: 10.1007/978-1-0716-0377-2_3.
9
Numeric pathologic lymph node classification shows prognostic superiority to topographic pN classification in esophageal squamous cell carcinoma.在食管鳞状细胞癌中,数字病理淋巴结分类显示出比拓扑学pN分类更好的预后优势。
Surgery. 2017 Oct;162(4):846-856. doi: 10.1016/j.surg.2017.06.013. Epub 2017 Jul 21.
10
Esophageal squamous cell carcinoma with special reference to its early stage.食管鳞状细胞癌,尤其关注其早期阶段。
Best Pract Res Clin Gastroenterol. 2013 Apr;27(2):171-86. doi: 10.1016/j.bpg.2013.03.010.

引用本文的文献

1
Changing landscape of advanced esophageal squamous cell carcinoma: Breakthroughs in systemic therapies (Review).晚期食管鳞状细胞癌的变化格局:全身治疗的突破(综述)
Oncol Rep. 2025 Oct;54(4). doi: 10.3892/or.2025.8953. Epub 2025 Jul 19.
2
Machine learning-enabled prediction of bone metastasis in esophageal cancer.基于机器学习的食管癌骨转移预测
Front Med (Lausanne). 2025 Jun 30;12:1620687. doi: 10.3389/fmed.2025.1620687. eCollection 2025.
3
Clinical Features and Prognosis of Cervical Esophageal Cancer.颈段食管癌的临床特征与预后
J Clin Med. 2025 May 29;14(11):3803. doi: 10.3390/jcm14113803.
4
YY1-induced DDX18 modulates EMT via the AKT/mTOR pathway in esophageal cancer: a novel therapeutic target.YY1诱导的DDX18通过AKT/mTOR信号通路调控食管癌的上皮-间质转化:一个新的治疗靶点
J Transl Med. 2025 May 20;23(1):562. doi: 10.1186/s12967-025-06555-7.
5
Clinical outcomes of esophageal squamous cell carcinoma in patients aged over 80 years.80岁以上食管鳞状细胞癌患者的临床结局
Korean J Intern Med. 2025 Mar;40(2):230-242. doi: 10.3904/kjim.2024.201. Epub 2025 Feb 21.
6
METTL3/IGF2BP2 Promotes the Malignant Progression of Esophageal Cancer by Activating the PIK3CA/AKT Pathway.METTL3/IGF2BP2通过激活PIK3CA/AKT通路促进食管癌的恶性进展。
Thorac Cancer. 2025 Feb;16(4):e70022. doi: 10.1111/1759-7714.70022.
7
Postoperative adjuvant immunotherapy for pathological stage II-IVa esophageal squamous cell carcinoma after radical surgery does not improve disease-free recurrence rates.根治性手术后,病理分期为II-IVa期的食管鳞状细胞癌患者接受术后辅助免疫治疗并不能提高无病复发率。
Front Med (Lausanne). 2024 Dec 13;11:1517001. doi: 10.3389/fmed.2024.1517001. eCollection 2024.
8
Prognostic significance and therapeutic potential of guanosine triphosphate cyclohydrolase 1 in esophageal squamous cell carcinoma: clinical implications of ferroptosis and lipid peroxidation regulation.鸟苷三磷酸环化水解酶1在食管鳞状细胞癌中的预后意义及治疗潜力:铁死亡和脂质过氧化调节的临床意义
Front Oncol. 2024 Dec 11;14:1459940. doi: 10.3389/fonc.2024.1459940. eCollection 2024.
9
Etomidate suppresses proliferation, migration, invasion, and glycolysis in esophageal cancer cells via PI3K/AKT pathway inhibition.依托咪酯通过抑制PI3K/AKT信号通路抑制食管癌细胞的增殖、迁移、侵袭和糖酵解。
Cytotechnology. 2025 Feb;77(1):4. doi: 10.1007/s10616-024-00661-y. Epub 2024 Nov 20.